Additional File 2 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Ningning Wang,Xianggui Wang,Guo‐Li Xiong,Ziyi Yang,Aiping Lu,Xiang Chen,Lei Shao,Tingjun Hou,Dongsheng Cao

DOI: https://doi.org/10.6084/m9.figshare.19607288

2022-01-01

Abstract:Additional file 2. The randomly generated negative datasets in the modeling process.

What problem does this paper attempt to address?

Additional File 1 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Ningning Wang,Xianggui Wang,Guo‐Li Xiong,Ziyi Yang,Aiping Lu,Xiang Chen,Lei Shao,Tingjun Hou,Dongsheng Cao

DOI: https://doi.org/10.6084/m9.figshare.19607285

2022-01-01

Abstract:Additional file 1. The final positive DDIs data and selected negative DDIs data with preprocessed descriptors.
Additional File 4 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Ningning Wang,Xianggui Wang,Guo‐Li Xiong,Ziyi Yang,Aiping Lu,Xiang Chen,Lei Shao,Tingjun Hou,Dongsheng Cao

DOI: https://doi.org/10.6084/m9.figshare.19607294

2022-01-01

Abstract:Additional file 4. The FDA-approved drugs for validation.
Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes

Ning-Ning Wang,Xiang-Gui Wang,Guo-Li Xiong,Zi-Yi Yang,Ai-Ping Lu,Xiang Chen,Shao Liu,Ting-Jun Hou,Dong-Sheng Cao

DOI: https://doi.org/10.1186/s13321-022-00602-x

2022-01-01

Journal of Cheminformatics

Abstract:Drug–drug interaction (DDI) often causes serious adverse reactions and thus results in inestimable economic and social loss. Currently, comprehensive DDI evaluation has become a major challenge in pharmaceutical research due to the time-consuming and costly process of the experimental assessment and it is of high necessity to develop effective in silico methods to predict and evaluate DDIs accurately and efficiently. In this study, based on a large number of substrates and inhibitors related to five important CYP450 isozymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4), a series of high-performance predictive models for metabolic DDIs were constructed by two machine learning methods (random forest and XGBoost) and 4 different types of descriptors (MOE_2D, CATS, ECFP4 and MACCS). To reduce the uncertainty of individual models, the consensus method was applied to yield more reliable predictions. A series of evaluations illustrated that the consensus models were more reliable and robust for the DDI predictions of new drug combination. For the internal validation, the whole prediction accuracy and AUC value of the DDI models were around 0.8 and 0.9, respectively. When it was applied to the external datasets, the model accuracy was 0.793 and 0.795 for multi-level validation and external validation, respectively. Furthermore, we also compared our model with some recently published tools and then applied the final model to predict FDA-approved drugs and proposed 54,013 possible drug pairs with potential DDIs. In summary, we developed a powerful DDI predictive model from the perspective of the CYP450 enzyme family and it will help a lot in the future drug development and clinical pharmacy research. Graphical Abstract
Additional File 2 of Machine Learning Models for Prediction of Invasion Klebsiella Pneumoniae Liver Abscess Syndrome in Diabetes Mellitus: a Singled Centered Retrospective Study

Feng Chen,Dechang Jia,Sufei Jiang,Xuemei Li,Hua Fang

DOI: https://doi.org/10.6084/m9.figshare.22767339

2023-01-01

Abstract:Additional file 2: Table S2. Tuning parameters of the predictive models.
Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates

Longqiang Li,Zhou Lu,Guixia Liu,Yun Tang,Weihua Li

DOI: https://doi.org/10.1021/acs.chemrestox.3c00065

2023-01-01

Chemical Research in Toxicology

Abstract:Cytochrome P450 2B6 (CYP2B6) is responsible for the metabolismof & SIM;7% of marketed drugs. The in vitro drug interaction studiesguidance for industry issued by the FDA stipulates that drug sponsorsneed to evaluate whether the investigated drugs interact with themajor drug-metabolizing P450s including CYP2B6. Therefore, there hasbeen greater attention to the development of predictive models forCYP2B6 inhibitors and substrates. In this study, conventional machinelearning and deep learning models were developed to predict CYP2B6inhibitors and substrates. Our results showed that the best CYP2B6inhibitor model yielded the AUC values of 0.95 and 0.75 with the 10-foldcross-validation and the test set, respectively, and the best CYP2B6substrate model produced the AUC values of 0.93 and 0.90 with the10-fold cross-validation and the test set, respectively. The generalizationability of the CYP2B6 inhibitor and substrate models was assessedby using the external validation sets. Several significant substructuralfragments relevant to CYP2B6 inhibitors and substrates were detectedvia frequency substructure analysis and information gain. In addition,the applicability domain of the models was defined by employing anonparametric method based on the probability density distribution.We anticipate that our results would be useful for the predictionof potential CYP2B6 inhibitors and substrates in the early stage ofdrug discovery.
Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition

Changda Gong,Yanjun Feng,Jieyu Zhu,Guixia Liu,Yun Tang,Weihua Li

DOI: https://doi.org/10.1002/jat.4601

IF: 3.3

2024-03-29

Journal of Applied Toxicology

Abstract:Cytochrome P450 (CYP) enzymes are involved in the metabolism of approximately 75% of marketed drugs. Inhibition of the major drug‐metabolizing P450s could alter drug metabolism and lead to undesirable drug–drug interactions. Therefore, it is of great significance to explore the inhibition of P450s in drug discovery. Currently, machine learning including deep learning algorithms has been widely used for constructing in silico models for the prediction of P450 inhibition. These models exhibited varying predictive performance depending on the use of machine learning algorithms and molecular representations. This leads to the difficulty in the selection of appropriate models for practical use. In this study, we systematically evaluated the conventional machine learning and deep learning models for three major P450 enzymes, CYP3A4, CYP2D6, and CYP2C9 from several perspectives, such as algorithms, molecular representation, and data partitioning strategies. Our results showed that the XGBoost and CatBoost algorithms coupled with the combined fingerprint/physicochemical descriptor features exhibited the best performance with Area Under Curve (AUC) of 0.92, while the deep learning models were generally inferior to the conventional machine learning models (average AUC reached 0.89) on the same test sets. We also found that data volume and sampling strategy had a minor effect on model performance. We anticipate that these results are helpful for the selection of molecular representations and machine learning/deep learning algorithms in the P450 model construction and the future model development of P450 inhibition.

toxicology
In Silico Prediction of CYP2C8 Inhibition with Machine-Learning Methods

Xiaoxiao Zhang,Piaopiao Zhao,Zhiyuan Wang,Xuan Xu,Guixia Liu,Yun Tang,Weihua Li

DOI: https://doi.org/10.1021/acs.chemrestox.1c00078

2021-01-01

Chemical Research in Toxicology

Abstract:Cytochrome P450 2C8 (CYP2C8) is a major drug-metabolizing enzyme in humans and is responsible for the metabolism of similar to 5% drugs in clinical use. Thus, inhibition of CYP2C8, which causes potential adverse drug events, cannot be neglected. The in vitro drug interaction studies guidelines for industry issued by the FDA also point out that it needs to be determined whether investigated drugs are CYP2C8 inhibitors before clinical trials. However, current studies mainly focus on predicting the inhibitors of other major P450 enzymes, and the importance of CYP2C8 inhibition has been overlooked. Therefore, there is a need to develop models for identifying potential CYP2C8 inhibition. In this study, in silico classification models for predicting CYP2C8 inhibition were built by five machine-learning methods combined with nine molecular fingerprints. The performance of the models built was evaluated by test and external validation sets. The best model had AUC values of 0.85 and 0.90 for the test and external validation sets, respectively. The applicability domain was analyzed based on the molecular similarity and exhibited an impact on the improvement of prediction accuracy. Furthermore, several representative privileged substructures such as 1H-benzo[d]imidazole, 1-phenyl-1H-pyrazole, and quinoline were identified by information gain and substructure frequency analysis. Overall, our results would be helpful for the prediction of CYP2C8 inhibition.
Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Yujie Shen,Qiang Huang,Yifan Zhang,Chi‐Yao Hsueh,Liang Zhou

DOI: https://doi.org/10.6084/m9.figshare.20279354

2022-01-01

Abstract:Additional file 11: Table S5. Enrichment analysis of sub-networks.
Survey of Machine Learning Techniques for Prediction of the Isoform Specificity of Cytochrome P450 Substrates.

Yi Xiong,Yanhua Qiao,Daisuke Kihara,Hui-Yuan Zhang,Xiaolei Zhu,Dong-Qing Wei

DOI: https://doi.org/10.2174/1389200219666181019094526

2019-01-01

Current Drug Metabolism

Abstract:Background: Determination or prediction of the Absorption, Distribution, Metabolism, and Excretion (ADME) properties of drug candidates and drug-induced toxicity plays crucial roles in drug discovery and development. Metabolism is one of the most complicated pharmacokinetic properties to be understood and predicted. However, experimental determination of the substrate binding, selectivity, sites and rates of metabolism is time-and recourse-consuming. In the phase I metabolism of foreign compounds (i.e., most of drugs), cytochrome P450 enzymes play a key role. To help develop drugs with proper ADME properties, computational models are highly desired to predict the ADME properties of drug candidates, particularly for drugs binding to cytochrome P450. Objective: This narrative review aims to briefly summarize machine learning techniques used in the prediction of the cytochrome P450 isoform specificity of drug candidates. Results: Both single-label and multi-label classification methods have demonstrated good performance on modelling and prediction of the isoform specificity of substrates based on their quantitative descriptors. Conclusion: This review provides a guide for researchers to develop machine learning-based methods to predict the cytochrome P450 isoform specificity of drug candidates
Prediction of cytochrome P450-mediated bioactivation using machine learning models and in vitro validation

Xin-Man Hu,Yan-Yao Hou,Xin-Ru Teng,Yong Liu,Yu Li,Wei Li,Yan Li,Chun-Zhi Ai

DOI: https://doi.org/10.1007/s00204-024-03701-w

2024-03-17

Archives of Toxicology

Abstract:Cytochrome P450 (P450)-mediated bioactivation, which can lead to the hepatotoxicity through the formation of reactive metabolites (RMs), has been regarded as the major problem of drug failures. Herein, we purposed to establish machine learning models to predict the bioactivation of P450. On the basis of the literature-derived bioactivation dataset, models for Benzene ring, Nitrogen heterocycle and Sulfur heterocycle were developed with machine learning methods, i.e., Random Forest, Random Subspace, SVM and Naïve Bayes. The models were assessed by metrics like "Precision", "Recall", " F -Measure", "AUC" (Area Under the Curve), etc. Random Forest algorithms illustrated the best predictability, with nice AUC values of 0.949, 0.973 and 0.958 for the test sets of Benzene ring, Nitrogen heterocycle and Sulfur heterocycle models, respectively. 2D descriptors like topological indices, 2D autocorrelations and Burden eigenvalues, etc. contributed most to the models. Furthermore, the models were applied to predict the occurrence of bioactivation of an external verification set. Drugs like selpercatinib, glafenine, encorafenib, etc. were predicted to undergo bioactivation into toxic RMs. In vitro, IC 50 shift experiment was performed to assess the potential of bioactivation to validate the prediction. Encorafenib and tirbanibulin were observed of bioactivation potential with shifts of 3–6 folds or so. Overall, this study provided a reliable and robust strategy to predict the P450-mediated bioactivation, which will be helpful to the assessment of adverse drug reactions (ADRs) in clinic and the design of new candidates with lower toxicities.

toxicology
Computational prediction for the metabolism of human UDP-glucuronosyltransferase 1A1 substrates

Ya-Bian Luo,Yan-Yao Hou,Zhen Wang,Xin-Man Hu,Wei Li,Yan Li,Yong Liu,Tong-Jiang Li,Chun-Zhi Ai

DOI: https://doi.org/10.1016/j.compbiomed.2022.105959

IF: 7.7

2022-10-01

Computers in Biology and Medicine

Abstract:UDP-glucuronosyltransferase (UGT) 1A1, one of the most important isoforms in UGTs superfamily, has attracted increasing concerns for its special role in the clearance and detoxification of endogenous and exogenous substances. To avoid the clinical drug-drug interactions, it is of great importance to have the knowledge of the metabolic profile of UGT1A1 substrates early. Herein, we purposed to establish machine learning models to predict the metabolic propeties of UGT1A1 substrates. On the basis of the literature-derived substrates database of UGT1A1, automatic metabolism prediction models for the aromatic hydroxyl (ArOH) and carboxyl (COOH) groups were developed with eight machine learning methods, among which, three methods, i.e. Random Forest, Random Subspace and J48, illustrated the best performance either for the aromatic hydroxyl and the carboxyl model. The models illustrated good robustness when they were evaluated with functions like “Precision”, “Recall”, “F-Measure”, “AUC”, “MCC”, etc. Nice accuracy was observed for the aromatic hydroxyl and carboxyl model of these methods, whose AUCs ranged from 0.901 to 0.997. Additionally, the ArOH model was applied to predict the UGT1A1-mediated metabolism of an external set. Two new unknown substrates, cytochrome P450 (CYPs)-mediated metabolites of gefitinib, were predicted and identified, which were validated by in vitro assays. In summary, this study provides a reliable and robust strategy to predict UGT1A1 metabolites, which will be helpful either in rational-optimization of drug metabolism or in avoiding drug-drug interactions in clinic.

engineering, biomedical,computer science, interdisciplinary applications,mathematical & computational biology,biology
Computational Prediction of the Isoform Specificity of Cytochrome P450 Substrates by an Improved Bayesian Method

Hao Dai,Yu-Xi Zheng,Xiao-Qi Shan,Yan-Yi Chu,Wei Wang,Yi Xiong,Dong-Qing Wei

DOI: https://doi.org/10.21203/rs.2.9738/v1

2019-01-01

Abstract:Abstract Cytochrome P450 (CYP) is the most important drug-metabolizing enzyme in human beings. Each CYP isoform is able to metabolize a large number of compounds, and if patients take more than one drugs during the treatment, it is possible that some drugs would be metabolized by the same CYP isoform, leading to potential drug-drug interactions and side effects. Therefore, it is necessary to investigate the isoform specificity of CYP substrates. In this study, we constructed a data set consisting of 10 major CYP isoforms associated with 776 substrates, and used machine learning methods to construct the predictive models based on the features of structural and physicochemical properties of substrates. We also proposed a new method called Improved Bayesian method, which is suitable for small data sets and is able to construct more stable and accurate predictive models compared with other traditional machine learning models. Based on this method, the predictive performance of our method got the accuracy of 86% for the independent test, which was significantly better to the existing models. We believe that our proposed method will facilitate the understanding of drug metabolisms and help the large-scale analysis of drug-drug interactions.
Prediction of Cytochrome P450 Inhibition Using a Deep Learning Approach and Substructure Pattern Recognition

Zhaoyang Chen,Le Zhang,Pei Zhang,Huizhu Guo,Ruiqiu Zhang,Ling Li,Xiao Li

DOI: https://doi.org/10.1021/acs.jcim.3c01396

2024-04-08

Abstract:Cytochrome P450 (CYP) is a family of enzymes that are responsible for about 75% of all metabolic reactions. Among them, CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 participate in the metabolism of most drugs and mediate many adverse drug reactions. Therefore, it is necessary to estimate the chemical inhibition of Cytochrome P450 enzymes in drug discovery and the food industry. In the past few decades, many computational models have been reported, and some provided good performance. However, there are still several issues that should be resolved for these models, such as single isoform, models with unbalanced performance, lack of structural characteristics analysis, and poor availability. In the present study, the deep learning models based on python using the Keras framework and TensorFlow were developed for the chemical inhibition of each CYP isoform. These models were established based on a large data set containing 85715 compounds extracted from the PubChem bioassay database. On external validation, the models provided good AUC values with 0.97, 0.94, 0.94, 0.96, and 0.94 for CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, respectively. The models can be freely accessed on the Web server named CYPi-DNNpredictor (cypi.sapredictor.cn), and the codes for the model were made open source in the Supporting Information. In addition, we also analyzed the structural characteristics of chemicals with CYP450 inhibition and detected the structural alerts (SAs), which should be responsible for the inhibition. The SAs were also made available online, named CYPi-SAdetector (cypisa.sapredictor.cn). The models can be used as a powerful tool for the prediction of CYP450 inhibitors, and the SAs should provide useful information for the mechanisms of Cytochrome P450 inhibition.
Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

Le Li,Zheng Chao,Un Waikeong,Jun Xiao,Yili Ge,Yanan Wang,Zezhong Xiong,Sheng Ma,Zhihua Wang,Zhiquan Hu,Xing Zeng

DOI: https://doi.org/10.6084/m9.figshare.22610398

2023-01-01

Abstract:Additional file 1. Gsea results of 3 clusters.
In Silico Prediction of Mitochondrial Toxicity of Chemicals Using Machine Learning Methods

Piaopiao Zhao,Yayuan Peng,Xuan Xu,Zhiyuan Wang,Zengrui Wu,Weihua Li,Yun Tang,Guixia Liu

DOI: https://doi.org/10.1002/jat.4141

IF: 3.3

2021-01-01

Journal of Applied Toxicology

Abstract:Mitochondria are important organelles in human cells, providing more than 95% of the energy. However, some drugs and environmental chemicals could induce mitochondrial dysfunction, which might cause complex diseases and even worsen the condition of patients with mitochondrial damage. Some drugs have been withdrawn from the market due to their severe mitochondrial toxicity, such as troglitazone. Therefore, there is an urgent need to develop models that could accurately predict the mitochondrial toxicity of chemicals. In this paper, suitable data were obtained from literature and databases first. Then nine types of fingerprints were used to characterize these compounds. Finally, different algorithms were used to build models. Meanwhile, the applicability domain of the prediction models was defined. We have also explored the structural alerts of mitochondrial toxicity, which would be helpful for medicinal chemists to better predict mitochondrial toxicity and further optimize lead compounds.
In Silico Prediction of Chemical Neurotoxicity Using Machine Learning.

Changsheng Jiang,Piaopiao Zhao,Weihua Li,Yun Tang,Guixia Liu

DOI: https://doi.org/10.1093/toxres/tfaa016

2020-01-01

Toxicology Research

Abstract:Neurotoxicity is one of the main causes of drug withdrawal, and the biological experimental methods of detecting neurotoxic toxicity are time-consuming and laborious. In addition, the existing computational prediction models of neurotoxicity still have some shortcomings. In response to these shortcomings, we collected a large number of data set of neurotoxicity and used PyBioMed molecular descriptors and eight machine learning algorithms to construct regression prediction models of chemical neurotoxicity. Through the cross-validation and test set validation of the models, it was found that the extra-trees regressor model had the best predictive effect on neurotoxicity ([Formula: see text] = 0.784). In addition, we get the applicability domain of the models by calculating the standard deviation distance and the lever distance of the training set. We also found that some molecular descriptors are closely related to neurotoxicity by calculating the contribution of the molecular descriptors to the models. Considering the accuracy of the regression models, we recommend using the extra-trees regressor model to predict the chemical autonomic neurotoxicity.
A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

Ke Han,Peigang Cao,Yu Wang,Fang Xie,Jiaqi Ma,Mengyao Yu,Jianchun Wang,Yaoqun Xu,Yu Zhang,Jie Wan

DOI: https://doi.org/10.3389/fphar.2021.814858

IF: 5.6

2022-01-28

Frontiers in Pharmacology

Abstract:Drug–drug interactions play a vital role in drug research. However, they may also cause adverse reactions in patients, with serious consequences. Manual detection of drug–drug interactions is time-consuming and expensive, so it is urgent to use computer methods to solve the problem. There are two ways for computers to identify drug interactions: one is to identify known drug interactions, and the other is to predict unknown drug interactions. In this paper, we review the research progress of machine learning in predicting unknown drug interactions. Among these methods, the literature-based method is special because it combines the extraction method of DDI and the prediction method of DDI. We first introduce the common databases, then briefly describe each method, and summarize the advantages and disadvantages of some prediction models. Finally, we discuss the challenges and prospects of machine learning methods in predicting drug interactions. This review aims to provide useful guidance for interested researchers to further promote bioinformatics algorithms to predict DDI.

pharmacology & pharmacy
Additional File 15 of Host DNA Contents in Fecal Metagenomics As a Biomarker for Intestinal Diseases and Effective Treatment

Puzi Jiang,Senying Lai,Sicheng Wu,Xing‐Ming Zhao,Wei‐Hua Chen

DOI: https://doi.org/10.6084/m9.figshare.12285437

2020-01-01

Abstract:Additional file 15: Table S11. AUC of classifiers based on species/pathways profiles (SRP057027) when predicting treatment response of external dataset (PRJNA384246). Features column means which type of features used for constructing random forest model.
Additional File 2 of Predicting Disease-Related Genes Using Integrated Biomedical Networks

Jiajie Peng,Kun Bai,Xuequn Shang,Guohua Wang,Shuilin Jin,Liang Cheng,Yadong Wang,Chen Jin

DOI: https://doi.org/10.6084/m9.figshare.c.3676615_d1.v1

2017-01-01

Abstract:Initial weight for difference evidence code. Additional file 2 is a table that lists the weight values for different evidence code. (PDF 42 kb)
ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches

Zhenxing Wu,Tailong Lei,Chao Shen,Zhe Wang,Dongsheng Cao,Tingjun Hou

DOI: https://doi.org/10.1021/acs.jcim.9b00801

IF: 6.162

2019-10-23

Journal of Chemical Information and Modeling

Abstract:Adverse effects induced by drug–drug interactions may result in early termination of drug development or even withdrawal of drugs from the market, and many drug–drug interactions are caused by the inhibition of cytochrome P450 (CYP450) enzymes. Therefore, the accurate prediction of the inhibition capability of a given compound against a specific CYP450 isoform is highly desirable. In this study, three ensemble learning methods, including random forest, gradient boosting decision tree, and eXtreme gradient boosting (XGBoost), and two deep learning methods, including deep neural networks and convolutional neural networks, were used to develop classification models to discriminate inhibitors and noninhibitors for five major CYP450 isoforms (1A2, 2C9, 2C19, 2D6, and 3A4). The results demonstrate that the ensemble learning models generally give better predictions than the deep learning models for the external test sets. Among all of the models, the XGBoost models achieve the best classification capability (average prediction accuracy of 90.4%) for the test sets, which even outperform the previously reported model developed by the multitask deep autoencoder neural network (88.5%). The Shapley additive explanation method was then used to interpret the models and analyze the misclassified molecules. The important molecular descriptors given by our models are consistent with the structural preferences for inhibitors of different CYP450 isoforms, which may provide valuable clues to detect potential drug–drug interactions in the early stage of drug discovery.

chemistry, multidisciplinary, medicinal,computer science, interdisciplinary applications, information systems

Additional File 2 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Additional File 1 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Additional File 4 of Machine Learning to Predict Metabolic Drug Interactions Related to Cytochrome P450 Isozymes

Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes

Additional File 2 of Machine Learning Models for Prediction of Invasion Klebsiella Pneumoniae Liver Abscess Syndrome in Diabetes Mellitus: a Singled Centered Retrospective Study

Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates

Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition

In Silico Prediction of CYP2C8 Inhibition with Machine-Learning Methods

Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Survey of Machine Learning Techniques for Prediction of the Isoform Specificity of Cytochrome P450 Substrates.

Prediction of cytochrome P450-mediated bioactivation using machine learning models and in vitro validation

Computational prediction for the metabolism of human UDP-glucuronosyltransferase 1A1 substrates

Computational Prediction of the Isoform Specificity of Cytochrome P450 Substrates by an Improved Bayesian Method

Prediction of Cytochrome P450 Inhibition Using a Deep Learning Approach and Substructure Pattern Recognition

Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

In Silico Prediction of Mitochondrial Toxicity of Chemicals Using Machine Learning Methods

In Silico Prediction of Chemical Neurotoxicity Using Machine Learning.

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

Additional File 15 of Host DNA Contents in Fecal Metagenomics As a Biomarker for Intestinal Diseases and Effective Treatment

Additional File 2 of Predicting Disease-Related Genes Using Integrated Biomedical Networks

ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches